相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy
Karen S. Wilcox et al.
NEUROPHARMACOLOGY (2020)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
Gregory L. Krauss et al.
LANCET NEUROLOGY (2020)
Cenobamate for focal seizures - a game changer?
Jacqueline A. French
NATURE REVIEWS NEUROLOGY (2020)
Effects of a potassium channel opener on brain injury and neurologic outcomes in an animal model of neonatal hypoxic-ischemic injury
Dayalan Sampath et al.
PEDIATRIC RESEARCH (2020)
Remarkably High Efficacy of Cenobamate in Adults With Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial
David G. Vossler
EPILEPSY CURRENTS (2020)
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study
Michael R. Sperling et al.
EPILEPSIA (2020)
Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending-Dose Studies in Healthy Subjects
Laurent Vernillet et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2020)
Molecular Mechanisms and Structural Basis of Retigabine Analogues in Regulating KCNQ2 Channel
Sai Shi et al.
JOURNAL OF MEMBRANE BIOLOGY (2020)
Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
Steve S. Chung et al.
NEUROLOGY (2020)
Mechanisms of action of currently used antiseizure drugs
Graeme J. Sills et al.
NEUROPHARMACOLOGY (2020)
Antiseizure drug efficacy and tolerability in established and novel drug discovery seizure models in outbred vs inbred mice
Zachery Koneval et al.
EPILEPSIA (2020)
Network meta-analysis of antiepileptic drugs in focal drug-resistant epilepsy
Tong Yao Hu et al.
EPILEPSY RESEARCH (2020)
Positive allosteric modulation of GABAA receptors by a novel antiepileptic drug cenobamate
Ramesh Sharma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Cenobamate (XCOPRI): Can preclinical and clinical evidence provide insight into its mechanism of action?
Michelle Guignet et al.
EPILEPSIA (2020)
Lennox-Gastaut syndrome: New treatments and treatments under investigation
S. Auvin
REVUE NEUROLOGIQUE (2020)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multi-centre, double-blind, randomised, placebo-controlled, dose-response trial (vol 19, pg 38, 2020)
G. L. Krauss et al.
LANCET NEUROLOGY (2020)
How to replace the lost keys? Strategies toward safer KV7 channel openers
Christian Bock et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Identifying Drugs that Bind Selectively to Intersubunit General Anesthetic Sites in the α1β3γ2 GABAAR Transmembrane Domain
Selwyn S. Jayakar et al.
MOLECULAR PHARMACOLOGY (2019)
GABA allosteric modulators: An overview of recent developments in non-benzodiazepine modulators
Viswas Raja Solomon et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons
Michiko Nakamura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting
Thomas Fowler et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
Flupirtine and retigabine as templates for ligand-based drug design of KV7.2/3 activators
Abdrrahman S. Surur et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
Stereoselective pharmacokinetic and pharmacodynamic analysis of a CNS-active sulphamoylphenyl carbamate derivative
David Bibi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
The etiological contribution of GABAergic plasticity to the pathogenesis of neuropathic pain
Caijuan Li et al.
MOLECULAR PAIN (2019)
Antiepileptic drugs: evolution of our knowledge and changes in drug trials
Emilio Perucca
EPILEPTIC DISORDERS (2019)
Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine-resistant amygdala kindling model
Cameron S. Metcalf et al.
EPILEPSIA OPEN (2019)
Neuropathic pain and Kv7 voltage-gated potassium channels: The potential role of Kv7 activators in the treatment of neuropathic pain
Alaa Abd-Elsayed et al.
MOLECULAR PAIN (2019)
GABA(A) receptor: Positive and negative allosteric modulators
Richard W. Olsen
NEUROPHARMACOLOGY (2018)
Epilepsy
Orrin Devinsky et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Carisbamate blockade of T-type voltage-gated calcium channels
Do Young Kim et al.
EPILEPSIA (2017)
Design and Comparative Evaluation of the Anticonvulsant Profile, Carbonic-Anhydrate Inhibition and Teratogenicity of Novel Carbamate Derivatives of Branched Aliphatic Carboxylic Acids with 4-Aminobenzensulfonamide
David Bibi et al.
NEUROCHEMICAL RESEARCH (2017)
Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs
Wolfgang Loscher
NEUROCHEMICAL RESEARCH (2017)
Anticonvulsant effect of flupirtine in an animal model of neonatal hypoxic-ischemic encephalopathy
Dayalan Sampath et al.
NEUROPHARMACOLOGY (2017)
Flupirtine and diazepam combination terminates established status epilepticus: results in three rodent models
Terry Zhang et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Tonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy
S. Schipper et al.
MOLECULAR NEUROBIOLOGY (2016)
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
Wolfgang Loescher et al.
CNS DRUGS (2016)
Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience
Yash D. Shah et al.
EPILEPSY & BEHAVIOR (2016)
Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABAA receptors
Manish Kumar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Challenges in the clinical development of new antiepileptic drugs
Valentina Franco et al.
PHARMACOLOGICAL RESEARCH (2016)
Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations
Yukiko Ihara et al.
PLOS ONE (2016)
Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet
Michael A. Rogawski et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What?
Roshan Puthenkalam et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl/aryl/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents
Shikha Kumari et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine
Felicia Klinger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The anticonvulsant retigabine is a subtype selective modulator of GABAA receptors
Marco Treven et al.
EPILEPSIA (2015)
A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures
Pavel Klein et al.
EPILEPSIA (2015)
The rise and fall of felbamate as a treatment for partial epilepsy - aplastic anemia and hepatic failure to blame?
Karan Thakkar et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Flupirtine effectively prevents development of acute neonatal seizures in an animal model of global hypoxia
Dayalan Sampath et al.
NEUROSCIENCE LETTERS (2015)
Antiepileptic drugs and adverse skin reactions: An update
Barbara Blaszczyk et al.
PHARMACOLOGICAL REPORTS (2015)
The rise and fall of felbamate as a treatment for partial epilepsy - aplastic anemia and hepatic failure to blame?
Karan Thakkar et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
New antiepileptic medication linked to blue discoloration of the skin and eyes
Sarah Clark et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2015)
Physical dependence liability of retigabine in rats
Michela Tessari et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial
Patrick Kwan et al.
EPILEPSIA (2014)
Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid
Tawfeeq Shekh-Ahmad et al.
EPILEPSIA (2014)
Efficacy and Safety of Carisbamate in Patients with Diabetic Neuropathy or Postherpetic Neuralgia: Results from 3 Randomized, Double-Blind Placebo-Controlled Trials
Timothy Smith et al.
PAIN PRACTICE (2014)
Pilocarpine-induced epilepsy in mice alters seizure thresholds and the efficacy of antiepileptic drugs in the 6-Hertz psychomotor seizure model
Marion Bankstahl et al.
EPILEPSY RESEARCH (2013)
Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI)
Meir Bialer et al.
EPILEPSY RESEARCH (2013)
Flupirtine, a re-discovered drug, revisited
Istvan Szelenyi
INFLAMMATION RESEARCH (2013)
Phenytoin Inhibits the Persistent Sodium Current in Neocortical Neurons by Modifying Its Inactivation Properties
Elisa Colombo et al.
PLOS ONE (2013)
Ezogabine: A Novel Antiepileptic for Adjunctive Treatment of Partial-Onset Seizures
Celene M. Amabile et al.
PHARMACOTHERAPY (2013)
A novel GABAA receptor pharmacology: drugs interacting with the α+β- interface
Werner Sieghart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine
Felicia Klinger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy
Martin J. Gunthorpe et al.
EPILEPSIA (2012)
The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: Implications for clinical use
Charles H. Large et al.
EPILEPSIA (2012)
How theories evolved concerning the mechanism of action of barbiturates
Wolfgang Loescher et al.
EPILEPSIA (2012)
Syntheses and Evaluation of Anticonvulsant Activity of Novel Branched Alkyl Carbamates
Naama Hen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Perampanel-new promise for refractory epilepsy?
Wolfgang Loescher et al.
NATURE REVIEWS NEUROLOGY (2012)
Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: A systematic review and meta-analysis
Joao Costa et al.
EPILEPSIA (2011)
Antiepileptic and Antiepileptogenic Performance of Carisbamate after Head Injury in the Rat: Blind and Randomized Studies
Clifford L. Eastman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Carisbamate (RWJ-333369) inhibits glutamate transmission in the granule cell of the dentate gyrus
Chun-Yao Lee et al.
NEUROPHARMACOLOGY (2011)
Carisbamate has powerful disease-modifying effects in the lithium-pilocarpine model of temporal lobe epilepsy
Jennifer Francois et al.
NEUROPHARMACOLOGY (2011)
Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling
Raman Sankar et al.
EPILEPSIA (2010)
Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: Correlation with other seizure and epilepsy models
Nicole M. Rowley et al.
EPILEPSY RESEARCH (2010)
Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)
Meir Bialer et al.
EPILEPSY RESEARCH (2010)
Emerging drugs for partial onset seizures
Wassim Nasreddine et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
A KCNQ Channel Opener for Experimental Neonatal Seizures and Status Epilepticus
YogendraSinh H. Raol et al.
ANNALS OF NEUROLOGY (2009)
Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro
B. J. Whalley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons
Yi Liu et al.
EPILEPSY RESEARCH (2009)
Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)
Meir Bialer et al.
EPILEPSY RESEARCH (2009)
Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs
Francesco Miceli et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Characterization of [S-35]t-butylbicyclophos-phorothionate ([S-35]TBPS) binding to GABA(A) receptors in postmortem human brain
J. R. Atack et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Idiosyncratic adverse reactions to antiepileptic drugs
Gaetano Zaccara et al.
EPILEPSIA (2007)
The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans
G. S. J. Mannens et al.
DRUG METABOLISM AND DISPOSITION (2007)
Carbamazepine and topiramate modulation of transient and persistent sodium currents studied in HEK293 cells expressing the Nav1.3 α-subunit
Guang-chun Sun et al.
EPILEPSIA (2007)
Felbamate: Consensus of current clinical experience
John M. Pellock et al.
EPILEPSY RESEARCH (2006)
Meprobamate-tranquilizer or anxiolytic?: A historical perspective
D Ramchandani et al.
PSYCHIATRIC QUARTERLY (2006)
Anxiolytic effects of maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels
MPG Korsgaard et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
MA Rogawski et al.
NATURE MEDICINE (2004)
Measuring the efficacy of antiepileptic drugs
R Mohanraj et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2003)
Mechanisms of idiosyncratic drug reactions: the case of felbamate
CM Dieckhaus et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2002)
Effects of the anticonvulsant retigabine on cultured cortical neurons: Changes in electroresponsive properties and synaptic transmission
JF Otto et al.
MOLECULAR PHARMACOLOGY (2002)
Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy
ME Barton et al.
EPILEPSY RESEARCH (2001)
Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine
L Tatulian et al.
JOURNAL OF NEUROSCIENCE (2001)
A neurochemical study of the novel antiepileptic drug retigabine in mouse brain
GJ Sills et al.
PHARMACOLOGICAL RESEARCH (2000)
Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine
MJ Main et al.
MOLECULAR PHARMACOLOGY (2000)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
